Carbetocin Versus Ergometrin in the Prevention of Postpartum Hemorrhage
Launched by NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS · Mar 6, 2020
Trial Information
Current as of May 16, 2025
Unknown status
Keywords
ClinConnect Summary
In the particular study the investigators will compare the effect of Carbetocin and ergometrin in the prevention of postpartum haemorrhage. It is a prospective comparative single blind randomized study which will be carried out in the G.N.M.A. "Elena Venizelou". The protocol will be filed in an international database before the initiation of the study (eg. ClinicalTrials.gov). The sample will be constituted by parturients that will undergo Caesarean section. The parturients will be divided in two groups: the group to which carbetocin will be administered and the group to which ergometrin wi...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Female gender Gestating Between 18-40 years No co-morbidity
- Exclusion Criteria:
- • Exclusion Criteria
- • Under age parturients
- • Parturients \>40 years of age
- • Multiple pregnancies
- • Parturients with abnormal placental adhesion
- • Parturients with two or more caesarian sections in the past
- • Parturients with haematological diseases
- • Parturients that receive anticoagulation therapy for a concomitant disease
- • Parturients with severe co-morbidity
- • Refusal to sign the consent form
- • Caesarian section under general anaesthesia
About National And Kapodistrian University Of Athens
The National and Kapodistrian University of Athens is a prestigious academic institution in Greece, renowned for its commitment to advancing medical research and education. With a strong emphasis on interdisciplinary collaboration, the university fosters innovative clinical trials aimed at improving healthcare outcomes. Its dedicated research teams leverage cutting-edge methodologies and a diverse range of expertise to address critical health challenges. As a clinical trial sponsor, the university prioritizes ethical standards and the welfare of participants, contributing significantly to the global body of medical knowledge and the development of new therapeutic interventions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Athens, Attiki, Greece
Patients applied
Trial Officials
Nikoleta Iakovidou
Study Director
Professor of Pediatrics NKUAthens
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials